drugset / Trial / NCT02728947
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To study the profile of Neupro patch administrated at 2 mg, 4 mg, 6 mg and 8 mg/day weekly in patients with early-stage Parkinson's disease
Timeline
- Start
- 2016-05
- Primary completion
- 2016-08
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rotigotine | Unknown | 2 mg | Other |
| Comparator | Rotigotine | Unknown | 4 mg | Other |
| Comparator | Rotigotine | Unknown | 6 mg | Other |
| Comparator | Rotigotine | Unknown | 8 mg | Other |